Glaxosmithkline Pharmaceuticals consolidated net profit rises 35.04% in the June 2019 quarter
Sales rise 7.11% to Rs 787.97 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 35.04% to Rs 113.54 crore in the quarter ended June 2019 as against Rs 84.08 crore during the previous quarter ended June 2018. Sales rose 7.11% to Rs 787.97 crore in the quarter ended June 2019 as against Rs 735.65 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales787.97735.65 7 OPM %20.9818.44 -PBDT195.17153.44 27 PBT176.11142.08 24 NP113.5484.08 35Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jul 22 2019 | 4:52 PM IST